This inventor holds 2 USPTO granted patents. Top assignees: Walter and Eliza Hall Institute of Medical Research, Other. Active years: 2009-2011.
Company Filing History:
1 out of 84 
1 out of 834,453 Years Active: 2009-2011
Title: The Innovations of Andrew J Harvey
Introduction
Andrew J Harvey is a notable inventor based in Parkville, Australia. He has made significant contributions to the field of medical research, particularly in the area of potassium channel modulation. With a total of 2 patents to his name, his work has implications for the treatment of various diseases.
Latest Patents
Harvey's latest patents include "Potassium channel blockers and uses thereof," which relates to compounds designed to modulate potassium channel activity in cells. Another significant patent is "Therapeutic ion channel blocking agents and methods of use thereof," which describes various divalent ligands based on khellinone derivatives. These derivatives are particularly useful in modulating potassium channel activity in cells, including Kv1.3 channels found in T-cells. The compounds developed by Harvey may also be beneficial in treating or preventing autoimmune and inflammatory diseases, such as multiple sclerosis.
Career Highlights
Throughout his career, Andrew J Harvey has worked with esteemed organizations, including the Walter and Eliza Hall Institute of Medical Research. His research has focused on innovative solutions to complex medical challenges, showcasing his dedication to advancing healthcare.
Collaborations
Harvey has collaborated with notable individuals in his field, including Jonathan Bayldon Baell and Heike Wulff. These partnerships have contributed to the depth and impact of his research.
Conclusion
Andrew J Harvey's contributions to the field of medical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of autoimmune and inflammatory diseases.